HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Nakaraang pagsara
$4.35
Sakop ng araw
$4.21 - $4.43
Sakop ng taon
$1.35 - $6.96
Market cap
393.23M USD
Average na Volume
535.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.57M | 79.08% |
Gastos sa pagpapatakbo | 26.10M | -29.16% |
Net na kita | -23.92M | 39.92% |
Net profit margin | -931.66 | 66.45% |
Kita sa bawat share | -0.22 | 96.33% |
EBITDA | -23.68M | 33.20% |
Aktuwal na % ng binabayarang buwis | 0.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 253.00M | 147.89% |
Kabuuang asset | 290.46M | 98.34% |
Kabuuang sagutin | 104.17M | -16.19% |
Kabuuang equity | 186.29M | — |
Natitirang share | 90.92M | — |
Presyo para makapag-book | 2.12 | — |
Return on assets | -26.32% | — |
Return on capital | -29.68% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -23.92M | 39.92% |
Cash mula sa mga operasyon | -15.53M | 52.94% |
Cash mula sa pag-invest | 16.85M | 295.44% |
Cash mula sa financing | 146.09M | 108,116.30% |
Net change in cash | 147.42M | 453.31% |
Malayang cash flow | -9.11M | 53.60% |
Tungkol
Itinatag
Mar 13, 2019
Headquarters
Website
Mga Empleyado
45
